Molecular Partners Presents Data From Ongoing Phase 1/2A Trial Of Mp0533 In Aml At EHA 2025
June 11 (Reuters) - Molecular Partners AG MOLN.S:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.